Bavor, Claire
Brotherton, Julia ML
Smith, Megan A
Prang, Khic-Houy
McDermott, Tracey
Rankin, Nicole M
Zammit, Claire M
Jennett, Chloe J
Sultana, Farhana
Machalek, Dorothy A
Nightingale, Claire E
,
Article History
Received: 2 June 2023
Accepted: 15 September 2023
First Online: 6 October 2023
Declarations
:
: The C4 CRE is a collaborative network being led by the Daffodil Centre (a joint venture between Cancer Council NSW and the University of Sydney), The Australian Centre for the Prevention of Cervical Cancer (ACPCC), the University of Melbourne and the Kirby Institute, University of New South Wales.JMLB is a former employee of ACPCC who has received contract funding from the Commonwealth Department of Health for work outside the current analysis relating to the National Cervical Screening Program. ACPCC has received equipment or supplies from Abbott, AusDiagnostics, BD, Cepheid, Copan, Hologic, Microbiologics, MicroBix, NRL, Qiagen, Rovers, Roche, and Seegene for research and validation studies. ACPCC has also received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana USA.MAS is an employee of Cancer Council NSW who has received contract funding from the Commonwealth Department of Health for work outside the current analysis relating to the National Cervical Screening Program.TM is a former employee of ACPCC who has received contract funding from the Commonwealth Department of Health for work outside the current analysis relating to the National Cervical Screening Program. ACPCC has received equipment or supplies from Abbott, AusDiagnostics, BD, Cepheid, Copan, Hologic, Microbiologics, MicroBix, NRL, Qiagen, Rovers, Roche, and Seegene for research and validation studies. ACPCC has also received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana USA.CEN is an employee of the University of Melbourne who has received contract funding from the Commonwealth Department of Health for work outside the current analysis relating to the National Cervical Screening Program.FS was involved in the STORIES project during her tenure at ACPCC until June 2019. She has since moved on to a new role at Telstra Health as an Epidemiologist. Telstra Health received contract funding from the Commonwealth Department of Health for managing the National Cancer Screening Register; however, this has had no impact of the conduct of the STORIES study.CJJ is an employee of Cancer Council NSW who has received contract funding from the Commonwealth Department of Health for work outside the current analysis relating to the National Cervical Screening Program.Members of the research team are employees of Cancer Council NSW (Authors MAS, CJJ) and ACPCC (Authors JMLB, TM) who were involved in the implementation of the Renewal and self-collection within the Renewal. In some cases, employees of ACPCC were invited to participate in the study. In instances where conflicts of interest were apparent between the participant and researcher, the interview was then performed by a research member without conflicts. All data was thematically analysed and deidentified with the wider study overseen by an Advisory Committee.CB has no competing interests to disclose.K-HP has no competing interests to disclose.NMR has no competing interests to disclose.CMZ has no competing interests to disclose.DAM has no competing interests to disclose.
: This study obtained ethics approval from the University of Melbourne Human Research Ethics Committee (1852257). The study was conducted in accordance with relevant guidelines and regulations. All participants provided informed consent prior to participating in the study.
: Not applicable – this manuscript does not include any individual person’s data.